Prostate-specific antigen (PSA) response in men with nonmetastatic castration-resistant prostate cancer (M0 CRPC) treated with enzalutamide (ENZA): Results from PROSPER

C.N. Sternberg, K. Fizazi, F. Saad, Per Rathenborg, N. Shore, E. Demirhan, K. Modelska, D. Phung, A. Krivoshik, M. Hussain

OriginalsprogEngelsk
Publikationsdatomar. 2018
StatusUdgivet - mar. 2018
BegivenhedEAU18 - Copenhagen, Danmark
Varighed: 16 mar. 201820 mar. 2018

Konference

KonferenceEAU18
Land/OmrådeDanmark
ByCopenhagen
Periode16/03/201820/03/2018

Citationsformater